Answer to Question 1
3
Rationale 1: The client should be monitored for hypokalemia.
Rationale 2: The client should be monitored for hypokalemia.
Rationale 3: Furosemide is a loop diuretic that can cause a decrease in serum potassium levels, so the client should be monitored for hypokalemia.
Rationale 4: The client should be monitored for hypokalemia.
Global Rationale: Furosemide is a loop diuretic that can cause a decrease in serum potassium levels, so the client should be monitored for hypokalemia. Loop diuretics do not cause hyperkalemia, hypercalcemia, or hypocalcemia.
Answer to Question 2
3
Rationale 1: Mannitol (Osmitrol) is an osmotic diuretic and does not increase RBC production.
Rationale 2: Chlorthalidone (Hygroton) is a thiazide-like diuretic and does not increase RBC production.
Rationale 3: Many patients with chronic renal failure will also have a deficiency of erythropoietin, a hormone secreted by the kidney. Erythropoietin serves as a primary signal to increase red blood cell production in the bone marrow. A synthetic form of erythropoietin, epoetin alfa (Epogen, Procrit), is effective in treating several disorders caused by a deficiency in red blood cells.
Rationale 4: Methazolamide (Neptazane) is a carbonic anhydrase inhibitor and does not increase RBC production.
Global Rationale: Many patients with chronic renal failure will also have a deficiency of erythropoietin, a hormone secreted by the kidney. Erythropoietin serves as a primary signal to increase red blood cell production in the bone marrow. A synthetic form of erythropoietin, epoetin alfa (Epogen, Procrit), is effective in treating several disorders caused by a deficiency in red blood cells. The other medications listed are not sure to increase red blood cell production.